Source BioScience is an international diagnostic, and genetic analysis and stability storage business serving the healthcare, life science research and pharma markets.
The group has its headquarters in Nottingham, UK where it operates state of the art reference laboratory facilities, with additional UK laboratory facilities in Cambridge, Oxford, Rochdale and Bellshill, European facilities in Berlin, Dublin and Tramore, and North American facilities in Los Angeles and Atlanta. Source BioScience is CPA, GLP and GCP accredited and is licensed by the Human Tissue Authority.
The LifeSciences division provides Sanger sequencing, Next Generation sequencing, bioinformatic analyses and a comprehensive portfolio of over 20 million clones and 200,000 antibodies.
The Healthcare division provides screening and reference laboratory diagnostic testing for cancer and other diseases and additional predictive testing for treatment optimisation for clinicians and patients.
The PharmaBiotech division supports the development and validation of clinical biomarkers for use as companion diagnostics in new drug launches or as pharmacodynamic endpoints for clinical and research studies. The division also provides pharma and biopharma storage services and equipment.